Vertex Pharmaceuticals
Price & Volume
Stats
See moreOpen | $537.48 |
Previous Close | $530.76 |
Day Range | $527.66-$544.62 |
52W Range | $406.67-$568.66 |
Market Cap | $140.2B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $12.5B |
Revenue Growth (YoY) | 12.5% |
Gross Profit (12 Mos) | $6.9B |
Diluted EPS | $17.17 |
News
See moreYahoo Finance • 20 hours ago
Vertex Slumps On Light Pain Drug Sales, But A Key Kidney Catalyst Lies Ahead
Yahoo Finance • 2 days ago
Vertex: Q3 Earnings Snapshot
Yahoo Finance • 2 days ago
Vertex raises 2026 revenue guidance following mixed Q3 results
Yahoo Finance • 2 days ago
Vertex Yo-Yos On Mixed Third-Quarter Report, Light Guidance Hike
About
CEO | Dr. Reshma Kewalramani FASN, M.D. |
CFO | Mr. Charles F. Wagner Jr. |
Address | 50 Northern Avenue, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6,400 |